PPIs may not promote infection, study finds

04/22/2013 | MedWire News (U.K.)

Patients taking a proton pump inhibitor had higher rates of Campylobacter and Salmonella infections than those not on the drugs, but data show they also were at higher risk for infection before beginning the medication, researchers reported in The American Journal of Gastroenterology. Researchers from Swansea University in the U.K. said infection risks increased over time for all patients. "Thus, increases in [gastrointestinal] infection after a PPI prescription are likely to be owing to a general increase in infection diagnosis rather than a result of the PPI prescription," according to the researchers.

View Full Article in:

MedWire News (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN